Evading host immune surveillance is one of the hallmarks of cancer. Immune checkpoint
therapy, which aims to eliminate cancer progression by reprogramming the antitumor immune …

PtSe 2, an emerging 2D group-10 transition metal dichalcogenide (TMD), has aroused
significant attention recently due to its intriguing physical properties. Here, the optical properties …

Triple‐negative breast cancer (TNBC) lacks a well‐defined molecular target and is associated
with poorer outcomes compared to other breast cancer subtypes. Programmed cell death …

The large‐scale applicability of Zn‐metal anodes is severely impeded by the issues such as
the dendrite growth, complicated hydrogen evolution, and uncontrollable passivation …

Hepatocellular carcinoma (HCC) accounts for most of primary liver cancer, of which five-year
survival rate remains low and chemoprevention has become a strategy to reduce disease …

Increasing evidence indicates that gut microbiota and its metabolites can influence the brain
function and the related behaviors. Trimethylamine N-oxide (TMAO), an indirect metabolite …

Treating cancer metastasis is of vital importance to prolong patients’ survival. Thioredoxin
reductase (TrxR) is overexpressed in many cancer types and has been recognized as an anti-…

Thioredoxin reductase 1 (TrxR1) is a pivotal intracellular redox sensor and antioxidant
enzyme. On the other hand, overexpression of TrxR1 is closely correlated with the initiation of …

There is an increased demand for efficient biomarkers for the diagnosis of non-small cell
lung cancer (NSCLC). This study aimed to evaluate plasma levels of TrxR activity in a large …

Sunitinib, a multi-targeted tyrosine kinase inhibitor, has been widely used in the therapy of
advanced renal cell cancer and imatinib-resistant gastrointestinal stromal tumors. However, …